Cargando…

The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb

None of the currently used anti-HIV-1 agents can effectively eliminate latent HIV-1 reservoirs, which is a major hurdle to a complete cure for AIDS. We report here that a novel oral BET inhibitor OTX015, a thienotriazolodiazepine compound that has entered phase Ib clinical development for advanced h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Panpan, Qu, Xiying, Shen, Yinzhong, Jiang, Zhengtao, Wang, Pengfei, Zeng, Hanxian, Ji, Haiyan, Deng, Junxiao, Yang, Xinyi, Li, Xian, Lu, Hongzhou, Zhu, Huanzhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828723/ https://www.ncbi.nlm.nih.gov/pubmed/27067814 http://dx.doi.org/10.1038/srep24100

Ejemplares similares

BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
por: Lu, Panpan, et al.
Publicado: (2017)

Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui
por: Wang, Pengfei, et al.
Publicado: (2017)

The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells
por: Pan, Hanyu, et al.
Publicado: (2017)

Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells
por: Ji, Haiyan, et al.
Publicado: (2018)

The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models
por: Servidei, Tiziana, et al.
Publicado: (2021)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

Specific and Stable Suppression of HIV Provirus Expression In Vitro by Chimeric Zinc Finger DNA Methyltransferase 1
por: Deng, Junxiao, et al.
Publicado: (2017)

The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2020)

CLRM-04. PHASE I/II SAFETY AND EFFICACY STUDY OF BET BROMODOMAIN INHIBITOR OTX-015 WITH OLAPARIB AND LOMUSTINE IN PATIENTS WITH RECURRENT GLIOBLASTOMA
por: Lam, Fred
Publicado: (2021)

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)
por: Djamai, Hanane, et al.
Publicado: (2021)

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations
por: Riveiro, Maria E., et al.
Publicado: (2016)

The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma
por: Yu, Bo, et al.
Publicado: (2022)

P-TEFb as a target to reactivate latent HIV: Two Brds are now in hand
por: Rice, Andrew P.
Publicado: (2013)

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
por: Gaudio, Eugenio, et al.
Publicado: (2016)

Scopoletin Reactivates Latent HIV-1 by Inducing NF-κB Expression without Global T Cell Activation
por: Zhu, Yuqi, et al.
Publicado: (2023)

PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF‐κB signaling
por: Yang, Xinyi, et al.
Publicado: (2020)

Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes
por: Boi, Michela, et al.
Publicado: (2016)

The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
por: Vázquez, Ramiro, et al.
Publicado: (2016)

OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence
por: Megiorni, Francesca, et al.
Publicado: (2021)

P-TEFb- the final frontier
por: Kohoutek, Jiri
Publicado: (2009)

P‐TEFb goes viral
por: Zaborowska, Justyna, et al.
Publicado: (2015)

Pandemic (H1N1) 2009, Shanghai, China
por: Shen, Yinzhong, et al.
Publicado: (2010)

OTX1 and OTX2 as Possible Molecular Markers of Sinonasal Carcinomas and Olfactory Neuroblastomas
por: Pirrone, Cristina, et al.
Publicado: (2017)

Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env(+) cells invivo
por: Pan, Hanyu, et al.
Publicado: (2023)

Megakaryocytic irreversible P-TEFb activation
por: Elagib, Kamaleldin E, et al.
Publicado: (2014)

A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter
por: Wu, Jun, et al.
Publicado: (2017)

Polyphenol Extracts from Grape Seeds and Apple Can Reactivate Latent HIV-1 Transcription through Promoting P-TEFb Release from 7SK snRNP
por: Wang, Cong, et al.
Publicado: (2022)

Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency through Increasing Histone Acetylation and Activation of NF-kappaB
por: Ying, Hao, et al.
Publicado: (2012)

Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells
por: Qu, Xiying, et al.
Publicado: (2013)

Photoreceptor cKO of OTX2 Enhances OTX2 Intercellular Transfer in the Retina and Causes Photophobia
por: Pensieri, Pasquale, et al.
Publicado: (2021)

FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat
por: Yang, Xinyi, et al.
Publicado: (2021)

P-TEFb as A Promising Therapeutic Target
por: Fujinaga, Koh
Publicado: (2020)

Homeoprotein OTX1 and OTX2 involvement in rat myenteric neuron adaptation after DNBS-induced colitis
por: Bistoletti, Michela, et al.
Publicado: (2020)

An Epigenetic Compound Library Screen Identifies BET Inhibitors That Promote HSV-1 and -2 Replication by Bridging P-TEFb to Viral Gene Promoters through BRD4
por: Ren, Ke, et al.
Publicado: (2016)

Structural basis of specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015
por: Dagbay, Kevin B., et al.
Publicado: (2020)

Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease
por: Sun, Yongzhan, et al.
Publicado: (2019)

Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR
por: Sedore, Stanley C., et al.
Publicado: (2007)

FBXO34 promotes latent HIV-1 activation by post-transcriptional modulation
por: Yang, Xinyi, et al.
Publicado: (2022)

HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
por: Jiang, Zhengtao, et al.
Publicado: (2021)

LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis
por: Ji, Xiaodan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_voldrohjlq6sgtvbc3dbptomff